 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
NanoPharmaceuticals.org is to foster and promote application of nanotechnology in the filed of
Pharmaceutical Science. This website is an honest attempt to give information about various
nanotechnologies, hot research publications, patents, news, companies etc. related to
NanoPharmaceuticals.
Who We Are?
|
Dr. Kumaresh S. Soppimath Research Scientist Department of Pharmaceutical Science Collage of Pharmacy, Western University of Health Sciences Pomona, CA, 91766, USA |
|
Dr. Guru V. Betageri, Professor and Chair Department of Pharmaceutical Science Collage of Pharmacy, Western University of Health Sciences Pomona, CA, 91766, USA |
Dr. Betageri obtained B.Pharm. from Karnatak University and M.Pharm. from Bangalore University. He was awarded Ph.D. degree in Pharmaceutical Sciences from the University of Alberta, Edmonton, Canada in 1987. Dr. Betageri joined National Cancer Institute as a visiting scientist at NIH, Bethesda, MD. He accepted a faculty appointment at Auburn University in 1989 and was promoted to Associate Professor in 1994. Dr. Betageri moved to Western University of Health Sciences in Pomona, California in 1998. He was promoted to Full Professor and Chairman of the Department of Pharmaceutical Sciences in 1999 and 2002 respectively. Dr. Betageri has advised eleven Ph.D. students and four M.S. students. His areas of interest are drug delivery using lipids and liposomes. Recently his research group is focusing on enhancement of dissolution and bioavailability using lipid based delivery system. He has obtained grant support from Federal agencies as well as more than 25 Pharmaceutical companies to support his research activities. Dr. Betageri has published more than 50 original research papers in refereed journals and presented more than 100 papers at National and International meetings. He has been invited speaker at various National and International Conferences and Pharmaceutical companies. He serves as consultant to various pharmaceutical companies at US and International companies. He is a reviewer for more than 12 pharmaceutical journals and he is also on the editorial board. He is a co- author on the book entitled “Liposome Drug Delivery” and he has co-authored several book chapters. He has been awarded three US patents on Pro-liposomal technologies. Dr. Betageri is an active member at American Association of Pharmaceutical Scientists, American Association of Colleges of Pharmacy and Controlled Release Society. |
|
Dr. Jean-Christophe Leroux Professeur agrégé / Associate professor Canada Research Chair in Drug Delivery Faculty of Pharmacy, University of Montreal C.P. 6128 Succ. centre-ville Montreal, Qc, H3C 3J7 Canada |
||||||
Dr. Amiji received his undergraduate degree in pharmacy from Northeastern University in 1988 and his PhD in pharmaceutics from Purdue University in 1992. His areas of specialization include polymeric biomaterials, advanced drug delivery systems, and nanomedical technologies. Dr. Amiji’s research interests include synthesis of novel polymeric materials for medical and pharmaceutical applications; surface modification of cationic polymers by the complexation- interpenetration method to develop biocompatible materials; preparation and characterization of polymeric membranes and microcapsules with controlled permeability properties for medical and pharmaceutical applications; target-specific drug and vaccine delivery systems for gastrointestinal tract infections; localized delivery of cytotoxic and antiangiogenic drugs for solid tumors in novel biodegradable polymeric nanoparticles intracellular delivery systems for drugs and genes using target- specific, long-circulating, biodegradable polymeric nanoparticles; gold and iron-gold core-shell nanoparticles for biosensing, imaging and delivery applications. His research has received sustained funding from the National Institutes of Health, National Science Foundation, local industries, and foundations. Dr. Amiji is the Associate Chair of Pharmaceutical Sciences Department and Co-Director of Northeastern University Nanomedicine Education and Research Consortium (NERC). He has two published books, Applied Physical Pharmacy and Polymeric Gene Delivery: Principles and Applications along with numerous manuscript publications. He has also received a number of awards including the 2003 Eurand Award for Innovative Oral Drug Delivery Research. |
|
Dr. S.M. MOGHIMI; BSc (Man.), PhD (Lond.) Senior Lecturer Molecular Targeting and Pharmaceutical Sciences School of Pharmacy, University of Brighton BN2 4GJ , UK |
| Moein Moghimi is a senior lecturer in at The School of Pharmacy, University of Brighton. Before joining Brighton he was the University Research Fellow at the Department of Pharmaceutical Sciences, University of Nottingham (UK). In the past 18 years, he has pioneered research in design and engineering of nanoparticulate delivery vehiches for parenteral site-specific targeting and medical imaging (splenotropic nanoparticles, lymphotropic agents and ‘phagocyte-resistant’ nanoparticles), and more recently in nanotoxicology of synthetic gene transfer vectors and lipid-based nanocarriers (stealth liposomes and lipid nanoparticles). He has published over 70 peer-reviewed original research papers and invited critical reviews in leading international journals as well as over 80 book chapters, business reports, editorials, and patents. Dr. Moghimi has served as invited theme editor for three issues of Advanced Drug Delivery Reviews (1995, 2000, and 2006), one issue of Current Drug Delivery (2005), and he is an editorial board member of the Journal of Liposome Research and Nanomedicine. He is also on the scientific advisory panel of Nanopharmaceuticals.com and Multimedia Distributed Knowledge Network in Nanotechnology-Nanopolis™ (France). In addition, Dr. Moghimi is actively a consultant to over 30 pharmaceutical, biotechnology, health, and food industries world-wide as well as investment banks, and has delivered more than 100 invited lectures in 20 countries. In 1985, he graduated in biochemistry from The University of Manchester (UK) and in 1989 completed a PhD in liposomes immunobiology at Charing Cross Hospital Medical School (Imperial College, University of London, UK). |
© 2005-2006 NanoPharmaceuticals.org. All rights reserved. No part of this Internet site may be
reproduced without prior written permission of the copyright holder. Terms & Disclaimer
